Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...

OUSA is an ETF that provides exposure to high-quality U.S. companies that pay regular dividends. The fund tracks the O’Shares ...

Shares of Merck & Co. Inc. MRK slipped 1.46% to $93.35 Wednesday, on what proved to be an all-around mixed trading session ...

In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...

The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...

The current Wall Street sell-off has wiped out billions in market value, hammering tech giants, banks, and airlines while ...

A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, Gardasil.